Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN ALKEM LABORATORIES LUPIN/
ALKEM LABORATORIES
 
P/E (TTM) x 40.7 37.5 108.6% View Chart
P/BV x 6.0 6.5 91.7% View Chart
Dividend Yield % 0.2 1.0 24.4%  

Financials

 LUPIN   ALKEM LABORATORIES
EQUITY SHARE DATA
    LUPIN
Mar-23
ALKEM LABORATORIES
Mar-23
LUPIN/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs7993,625 22.0%   
Low Rs5832,835 20.6%   
Sales per share (Unadj.) Rs365.8970.1 37.7%  
Earnings per share (Unadj.) Rs9.884.2 11.7%  
Cash flow per share (Unadj.) Rs29.2110.2 26.5%  
Dividends per share (Unadj.) Rs4.0050.00 8.0%  
Avg Dividend yield %0.61.5 37.4%  
Book value per share (Unadj.) Rs270.7756.4 35.8%  
Shares outstanding (eoy) m454.98119.57 380.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.93.3 56.7%   
Avg P/E ratio x70.238.4 183.1%  
P/CF ratio (eoy) x23.729.3 80.7%  
Price / Book Value ratio x2.64.3 59.8%  
Dividend payout %40.759.4 68.5%   
Avg Mkt Cap Rs m314,381386,207 81.4%   
No. of employees `000NANA-   
Total wages/salary Rs m30,87221,314 144.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m166,417115,993 143.5%  
Other income Rs m1,5092,161 69.8%   
Total revenues Rs m167,926118,153 142.1%   
Gross profit Rs m17,20615,065 114.2%  
Depreciation Rs m8,8073,104 283.7%   
Interest Rs m2,7431,074 255.5%   
Profit before tax Rs m7,16513,048 54.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,6882,980 90.2%   
Profit after tax Rs m4,47710,068 44.5%  
Gross profit margin %10.313.0 79.6%  
Effective tax rate %37.522.8 164.3%   
Net profit margin %2.78.7 31.0%  
BALANCE SHEET DATA
Current assets Rs m124,51386,064 144.7%   
Current liabilities Rs m92,65437,071 249.9%   
Net working cap to sales %19.142.2 45.3%  
Current ratio x1.32.3 57.9%  
Inventory Days Days2633 80.5%  
Debtors Days Days9867 146.5%  
Net fixed assets Rs m103,49037,245 277.9%   
Share capital Rs m910239 380.6%   
"Free" reserves Rs m122,24690,208 135.5%   
Net worth Rs m123,15690,447 136.2%   
Long term debt Rs m2750-   
Total assets Rs m228,003124,541 183.1%  
Interest coverage x3.613.2 27.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.9 78.4%   
Return on assets %3.28.9 35.4%  
Return on equity %3.611.1 32.7%  
Return on capital %8.015.6 51.4%  
Exports to sales %014.6 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA16,916 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m48,05716,916 284.1%   
Fx outflow Rs m21,7524,190 519.2%   
Net fx Rs m26,30612,727 206.7%   
CASH FLOW
From Operations Rs m18,97216,825 112.8%  
From Investments Rs m-12,8681,128 -1,140.3%  
From Financial Activity Rs m-3,373-17,608 19.2%  
Net Cashflow Rs m2,732416 656.5%  

Share Holding

Indian Promoters % 46.8 56.7 82.4%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 45.8 24.4 187.9%  
FIIs % 16.1 8.5 189.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.0 43.3 122.4%  
Shareholders   281,542 65,184 431.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Lupin vs ALKEM LABORATORIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Lupin vs ALKEM LABORATORIES Share Price Performance

Period Lupin ALKEM LABORATORIES S&P BSE HEALTHCARE
1-Day 1.23% -1.18% 1.18%
1-Month 0.15% -0.99% -0.75%
1-Year 151.14% 52.26% 61.82%
3-Year CAGR 17.13% 21.70% 18.16%
5-Year CAGR 17.42% 22.99% 19.79%

* Compound Annual Growth Rate

Here are more details on the Lupin share price and the ALKEM LABORATORIES share price.

Moving on to shareholding structures...

The promoters of Lupin hold a 47.0% stake in the company. In case of ALKEM LABORATORIES the stake stands at 56.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Lupin and the shareholding pattern of ALKEM LABORATORIES.

Finally, a word on dividends...

In the most recent financial year, Lupin paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 40.7%.

ALKEM LABORATORIES paid Rs 50.0, and its dividend payout ratio stood at 59.4%.

You may visit here to review the dividend history of Lupin, and the dividend history of ALKEM LABORATORIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.